Carlyle Group has appointed Goldman Sachs and JM Financial as lead advisors for a potential initial public offering of its India-based healthcare revenue cycle management business, according to sources familiar with the transaction. The planned offering is expected to raise approximately $400 million and would represent a significant expansion of capital market activities in India's growing healthcare services sector.
The move reflects Carlyle's strategy to monetize its stake in the revenue cycle management business, which provides back-office and administrative services to healthcare providers. By taking the company public in India, Carlyle aims to tap into strong investor appetite for healthcare services and business process outsourcing companies in the region.
The engagement of both Goldman Sachs, a leading global investment bank, and JM Financial, a prominent Indian financial services firm, underscores the transaction's significance and the commitment to executing a robust listing process in the Indian capital markets.
